The current state of pemetrexed in ovarian cancer

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.9, 2013-09, pp. : 1201-1210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pemetrexed disodium in ovarian cancer treatment

By Morotti M Valenzano Menada M Venturini PL Mammoliti S Ferrero S

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 4, 2012-04 ,pp. : 437-449

Informa Healthcare

Access to resources Recommend Favorite

Current treatment for ovarian cancer

By Eltabbakh G.H. Awtrey C.S.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 109-124

Informa Healthcare

Access to resources Recommend Favorite

Pharmaceutical Management of Ovarian Cancer: Current Status

By Markman Maurie

Drugs, Vol. 68, Iss. 6, 2008-01 ,pp. : 771-789

Adis International

Access to resources Recommend Favorite

Ovarian Cancer Biomarkers: Current Options and Future Promise

By Coticchia Christine M. Yang Jiang Moses Marsha A.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 8, 2008-09 ,pp. : 795-802

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Current treatment and clinical trials in ovarian cancer

By Han Liz Y Kipps Emma Kaye Stan B

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 4, 2010-04 ,pp. : 521-534

Informa Healthcare

Access to resources Recommend Favorite